Cardiometabolic Disorders in Psoriatic Disease.

about

Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.Psoriasis-Related Visceral Adiposity and Arterial Inflammation: A New Adiposity Disease Entity?

P2860

Q47218445-64F43EED-A2BF-46B1-A93E-90D4197AFF84 Q50063989-8F037526-4DEE-45F2-860D-A0601E21A073

P2860

Cardiometabolic Disorders in Psoriatic Disease.

Item

http://www.wikidata.org/entity/Q40069191

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cardiometabolic Disorders in Psoriatic Disease.

@en

type

Item

label

Cardiometabolic Disorders in Psoriatic Disease.

@en

prefLabel

Cardiometabolic Disorders in Psoriatic Disease.

@en

P1476

Cardiometabolic Disorders in Psoriatic Disease.

@en

P2093

Curtis Sobchak

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis

Atherosclerosis in psoriatic disease: latest evidence and clinical implications

Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials.

Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.

Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review.

Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.

Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease Initia

Attributable risk estimate of severe psoriasis on major cardiovascular events

P2888

s11926-017-0692-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-017-0692-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lihi Eder

P577

2017-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28844116

http://www.w3.org/2001/XMLSchema#string

Cardiometabolic Disorders in Psoriatic Disease.

about

P2860

P2860

Cardiometabolic Disorders in Psoriatic Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698